FDA: Safety Label Changes Required for BCMA-, CD19-Directed CAR T-Cell Therapies
The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.
Stay updated with breaking news from Medication Guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.
The US Food and Drug Administration has issued a new warning about the possible risk of secondary cancers in cancer patients who have been treated with a form of immunotherapy
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase...
CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.
ROCKLAND, Mass.--(BUSINESS WIRE)--Jan 22, 2024--